Company Description
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally.
The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.
In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection.
Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications.
Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines.
Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
| Country | United States |
| Founded | 1989 |
| IPO Date | Nov 3, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Jan Haverhals |
Contact Details
Address: 425 Eagle Rock Avenue, Suite 403 Roseland, New Jersey 07068 United States | |
| Phone | 973 535 2717 |
| Website | milestonescientific.com |
Stock Details
| Ticker Symbol | MLSS |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000855683 |
| CUSIP Number | 59935P209 |
| ISIN Number | US59935P2092 |
| Employer ID | 13-3545623 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Jan Adriaan Haverhals | President, Chief Executive Officer and Director |
| Leonard A. Osser | Founder and Vice Chairman |
| James Hippett J.D. | Senior Vice President of Global Sales and Business Development |
| Keisha Harcum | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 20, 2024 | 8-K | Current Report |
| Dec 19, 2024 | 144 | Filing |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | 8-K | Current Report |
| Sep 27, 2024 | 8-K | Current Report |
| Sep 11, 2024 | 144 | Filing |
| Aug 14, 2024 | 10-Q | Quarterly Report |
| Jul 18, 2024 | 8-K | Current Report |
| Jun 5, 2024 | DEF 14A | Other definitive proxy statements |
| May 15, 2024 | 10-Q | Quarterly Report |